Company · Reading
Aventis Pharma Limited
Wholesale of pharmaceutical goods
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Aventis Pharma Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 36
- Rippondeep Ubhi 2024-2026 View profile
- Jessamy Rachel Baird 2021-2024 View profile
- Usman Khan 2021-2026 View profile
- Gordon Michael Tillett 2021-2021 View profile
- Hugo Rupert Alexander Fry 2017-2021 View profile
- Francois-Xavier Duhalde 2016-2021 View profile
- David Mathias Loew 2015-2016 View profile
- Tarja Johanna Stenvall 2014-2016 View profile
- Peter Antoan Guenter 2012-2015 View profile
- Andrew Michael James Prosser 2010-2016 View profile
- Stephen Philip Oldfield 2010-2014 View profile
- Belen Garijo 2006-2011 View profile
- Gilles Denis Brisson 2004-2006 View profile
- Nigel Stanley Brooksby 2004-2010 View profile
- Guillaume Adrien De Forceville 2004-2007 View profile
- Pierre Chancel 2004-2004 View profile
- Laszlo Szapary 2000-2004 View profile
- David Hugh Thomas Rees 2000-2004 View profile
- James Paul Mitchum 1999-2002 View profile
- David Thomas Ashton 1997-2000 View profile
- Peter Loescher 1997-1999 View profile
- Jean Michel Quinot 1997-1997 View profile
- Dr Wolfgang Schikorr 1995-1997 View profile
- Dr Elliot Graham Brown 1993-1995 View profile
- Paul Douglas Victor Cannon 1993-1995 View profile
- Thomas Ronald Irwin 1993 View profile
- Peter William Ladell 2000 View profile
- Guiseppe Violini 1993 View profile
- Harold Crossley Masheter 1993 View profile
- Michael James Mcclellan 2007-2010 View profile
- Helen Roberts 2004-2008 View profile
- Suzanne Elaine Smith 2004-2004 View profile
- David John Nicholls 1999-2004 View profile
- Christopher Edward Clapham 1995-2001 View profile
- Fernando Arozena 1992-1995 View profile
- William Wesley Wales 1992 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
Public contracts won
3 contractsFrom Contracts Finder and Find a Tender, the UK Government's public procurement notices, under the Open Government Licence v3.0. Matched to this organisation by company number, charity number or exact name and postcode; every figure links to its source notice.
-
NHS National Branded Interim - 1 June 2026
Provision of an NHS National Branded Interim - 1 June 2026 01/06/2026 - 30/04/2028 23 Months with an option or options to extend at the discretion of the authority up to a maximum of 25 months
Framework -
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
NHS Branded Medicines Tranche B - Lot 1 - London & South of England - CM/PHR/25/5731 Period of Framework Agreement: 1 September 2026 to 31 August 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or per…
Framework -
Generic, Branded Generic & Proprietary Medicinal Products - Group 18
Generic, Branded Generic & Proprietary Medicinal Products - Group 18 (6345404)
About
- What it does
- Wholesale of pharmaceutical goods
- Incorporated
- 18/12/1980
- Registered office
- Reading
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Sanofi-Aventis UK Holdings Limited
75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06
Group
- Aventis Pharma Limited
is controlled by Sanofi-Aventis UK Holdings Limited
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register - Sanofi-Aventis UK Holdings Limited
is controlled by Sanofi-Synthelabo UK Limited
Evidence
active 25-50% shares, 25-50% voting · notified 2016-04-06 · source: Companies House PSC register
Ultimately controlled by Sanofi-Synthelabo UK Limited.
11 other companies in this group
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
2 directors on the board
- Walaa Mostafa Abbas Awad Mohamed Director · appointed 2026
- Ahmed Mohamed Moustafa Moussa Director · appointed 2026
First-time vs portfolio directors
Portfolio (2)
- Walaa Mostafa Abbas Awad Mohamed Director · appointed 2026
- Ahmed Mohamed Moustafa Moussa Director · appointed 2026
Left in the last 12 months
- Rippondeep Ubhi Director · appointed 2024 · resigned 2026
- Usman Khan Director · appointed 2021 · resigned 2026
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 01535640
- Status
- Active
- Type
- Private Limited Company
- Accounts next due
- 30/09/2027
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data